TMO - Thermo Fisher Scientific Inc.
NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD
Valuation Measures
| Market Cap (intraday) 5 | 128.52B |
| Enterprise Value 3 | 144.05B |
| Trailing P/E | 36.05 |
| Forward P/E 1 | 23.57 |
| PEG Ratio (5 yr expected) 1 | 2.28 |
| Price/Sales (ttm) | 5.10 |
| Price/Book (mrq) | 4.38 |
| Enterprise Value/Revenue 3 | 5.71 |
| Enterprise Value/EBITDA 6 | 22.32 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.12 |
| 52-Week Change 3 | 36.37% |
| S&P500 52-Week Change 3 | 21.87% |
| 52 Week High 3 | 322.17 |
| 52 Week Low 3 | 208.34 |
| 50-Day Moving Average 3 | 305.68 |
| 200-Day Moving Average 3 | 290.19 |
Share Statistics
| Avg Vol (3 month) 3 | 1.34M |
| Avg Vol (10 day) 3 | 1.09M |
| Shares Outstanding 5 | 400.99M |
| Float | 400.01M |
| % Held by Insiders 1 | 0.19% |
| % Held by Institutions 1 | 90.67% |
| Shares Short (Nov 29, 2019) 4 | 3.57M |
| Short Ratio (Nov 29, 2019) 4 | 2.92 |
| Short % of Float (Nov 29, 2019) 4 | 0.90% |
| Short % of Shares Outstanding (Nov 29, 2019) 4 | 0.89% |
| Shares Short (prior month Oct 31, 2019) 4 | 3.3M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 0.76 |
| Forward Annual Dividend Yield 4 | 0.24% |
| Trailing Annual Dividend Rate 3 | 0.74 |
| Trailing Annual Dividend Yield 3 | 0.23% |
| 5 Year Average Dividend Yield 4 | 0.36 |
| Payout Ratio 4 | 8.32% |
| Dividend Date 3 | Jan 15, 2020 |
| Ex-Dividend Date 4 | Dec 16, 2019 |
| Last Split Factor (new per old) 2 | 2/3 |
| Last Split Date 3 | Jun 6, 1996 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2018 |
| Most Recent Quarter (mrq) | Sep 28, 2019 |
Profitability
| Profit Margin | 14.24% |
| Operating Margin (ttm) | 16.64% |
Management Effectiveness
| Return on Assets (ttm) | 4.69% |
| Return on Equity (ttm) | 12.77% |
Income Statement
| Revenue (ttm) | 25.22B |
| Revenue Per Share (ttm) | 62.97 |
| Quarterly Revenue Growth (yoy) | 5.90% |
| Gross Profit (ttm) | 10.87B |
| EBITDA | 6.46B |
| Net Income Avi to Common (ttm) | 3.59B |
| Diluted EPS (ttm) | 8.89 |
| Quarterly Earnings Growth (yoy) | 7.20% |
Balance Sheet
| Total Cash (mrq) | 1.27B |
| Total Cash Per Share (mrq) | 3.17 |
| Total Debt (mrq) | 17.77B |
| Total Debt/Equity (mrq) | 60.54 |
| Current Ratio (mrq) | 1.80 |
| Book Value Per Share (mrq) | 73.21 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.86B |
| Levered Free Cash Flow (ttm) | 3.79B |